PRELLIS BIOLOGICS
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier. The company was founded in 2016 and is based in San Francisco, California.
PRELLIS BIOLOGICS
Industry:
3D Printing Biopharma Biotechnology Therapeutics
Founded:
2016-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.prellisbio.com
Total Employee:
11+
Status:
Active
Contact:
510-200-7698
Email Addresses:
[email protected]
Total Funding:
64.87 M USD
Technology used in webpage:
SSL By Default Content Delivery Network JsDelivr Cloudflare JS CDN JS BootstrapCDN GStatic Google Static Content JQuery CDN Fastly Google Cloud Iowa
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Felix Biotechnology
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lucas Venture Group
Lucas Venture Group investment in Series C - Prellis Biologics
True Ventures
True Ventures investment in Series C - Prellis Biologics
SOSV
SOSV investment in Series C - Prellis Biologics
Avidity Partners
Avidity Partners investment in Series C - Prellis Biologics
Celesta Capital
Celesta Capital investment in Series C - Prellis Biologics
Khosla Ventures
Khosla Ventures investment in Series C - Prellis Biologics
SOSV
SOSV investment in Series B - Prellis Biologics
SOSV
SOSV investment in Convertible Note - Prellis Biologics
SOSV
SOSV investment in Convertible Note - Prellis Biologics
IndieBio
IndieBio investment in Convertible Note - Prellis Biologics
Key Employee Changes
Official Site Inspections
http://www.prellisbio.com Semrush global rank: 4.02 M Semrush visits lastest month: 3.07 K
- Host name: 104.26.0.183
- IP address: 104.26.0.183
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
